HELP — Heidelberg decision aid for lung cancer patients: a randomized controlled clinical trial

por Deis, Nicole, Unsöld, Laura, Siegle, Anja, Krisam, Johannes, Thomas, Michael, Villalobos, Matthias
Publicado 2023

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

por Reinmuth, Niels, Payer, Nadine, Muley, Thomas, Hoffmann, Hans, Herth, Felix JF, Villalobos, Matthias, Thomas, Michael
Publicado 2013

What patients with lung cancer with comorbidity tell us about interprofessional collaborative care across healthcare sectors: qualitative interview study

por Bossert, Jasmin, Forstner, Johanna, Villalobos, Matthias, Siegle, Anja, Jung, Corinna, Deis, Nicole, Thomas, Michael, Wensing, Michel, Krug, Katja
Publicado 2020

Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study

por Krug, Katja, Bossert, Jasmin, Stooß, Lydia, Siegle, Anja, Villalobos, Matthias, Hagelskamp, Laura, Jung, Corinna, Thomas, Michael, Wensing, Michel
Publicado 2020

Patient expectations are better for immunotherapy than traditional chemotherapy for cancer

por Ihrig, Andreas, Richter, Jenniffer, Grüllich, Carsten, Apostolidis, Leonidas, Horak, Peter, Villalobos, Matthias, Grapp, Miriam, Friederich, Hans-Christoph, Maatouk, Imad
Publicado 2020

Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity

por Bossert, Jasmin, Wensing, Michel, Thomas, Michael, Villalobos, Matthias, Jung, Corinna, Siegle, Anja, Hagelskamp, Laura, Deis, Nicole, Jünger, Jana, Krug, Katja
Publicado 2020

Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study

por Bossert, Jasmin, Ludwig, Marion, Wronski, Pamela, Koetsenruijter, Jan, Krug, Katja, Villalobos, Matthias, Jacob, Josephine, Walker, Jochen, Thomas, Michael, Wensing, Michel
Publicado 2021

Individual difficulties and resources – a qualitative analysis in patients with advanced lung cancer and their relatives

por Sparla, Anika, Flach-Vorgang, Sebastian, Villalobos, Matthias, Krug, Katja, Kamradt, Martina, Coulibaly, Kadiatou, Szecsenyi, Joachim, Thomas, Michael, Gusset-Bährer, Sinikka, Ose, Dominik
Publicado 2016

Reflection of illness and strategies for handling advanced lung cancer – a qualitative analysis in patients and their relatives

por Sparla, Anika, Flach-Vorgang, Sebastian, Villalobos, Matthias, Krug, Katja, Kamradt, Martina, Coulibaly, Kadiatou, Szecsenyi, Joachim, Thomas, Michael, Gusset-Bährer, Sinikka, Ose, Dominik
Publicado 2017

The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial

por Siegle, Anja, Villalobos, Matthias, Bossert, Jasmin, Krug, Katja, Hagelskamp, Laura, Krisam, Johannes, Handtke, Violet, Deis, Nicole, Jünger, Jana, Wensing, Michel, Thomas, Michael
Publicado 2018

Factors related to implementation of an interprofessional communication concept in thoracic oncology: a mixed-methods study

por Krug, Katja, Bossert, Jasmin, Möllinger, Sophia, Deis, Nicole, Unsöld, Laura, Siegle, Anja, Villalobos, Matthias, Hagelskamp, Laura, Jung, Corinna, Thomas, Michael, Wensing, Michel
Publicado 2022

Communication with patients with limited prognosis—an integrative mixed-methods evaluation study

por Siegle, Anja, Unsöld, Laura, Deis, Nicole, Krug, Katja, Bossert, Jasmin, Krisam, Johannes, Jung, Corinna, Jünger, Jana, Wensing, Michel, Thomas, Michael, Villalobos, Matthias
Publicado 2022

Effects of an Interprofessional Communication Approach on Support Needs, Quality of Life, and Mood of Patients with Advanced Lung Cancer: A Randomized Trial

por Krug, Katja, Bossert, Jasmin, Deis, Nicole, Krisam, Johannes, Villalobos, Matthias, Siegle, Anja, Jung, Corinna, Hagelskamp, Laura, Unsöld, Laura, Jünger, Jana, Thomas, Michael, Wensing, Michel
Publicado 2021

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab

por Villalobos, Matthias, Czapiewski, Piotr, Reinmuth, Niels, Fischer, Jürgen R., Andreas, Stefan, Kortsik, Cornelius, Serke, Monika, Wolf, Martin, Neuser, Petra, Reuss, Alexander, Schnabel, Philipp A., Thomas, Michael
Publicado 2019